Roche
ROG.SW
#33
Rank
NZ$614.05 B
Marketcap
NZ$771.80
Share price
-0.53%
Change (1 day)
43.55%
Change (1 year)

Market capitalization of Roche (ROG.SW)

Market cap: NZ$614.05 Billion

As of February 2026 Roche has a market cap of NZ$614.05 Billion. This makes Roche the world's 33th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Roche from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$614.05 B6.22%
2025NZ$578.09 B44.52%
2024NZ$400.02 B8.08%
2023NZ$370.09 B-9.47%
2022NZ$408.80 B-22.36%
2021NZ$526.52 B26.97%
2020NZ$414.68 B1.06%
2019NZ$410.33 B30.67%
2018NZ$314.02 B3.8%
2017NZ$302.54 B7.06%
2016NZ$282.58 B-18.88%
2015NZ$348.34 B17.82%
2014NZ$295.66 B2.02%
2013NZ$289.80 B-24.43%
2012NZ$383.47 B103.16%
2011NZ$188.75 B14.26%
2010NZ$165.19 B-19.39%
2009NZ$204.94 B-12.12%
2008NZ$233.21 B17.91%
2007NZ$197.78 B-9.83%
2006NZ$219.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$956.25 B 55.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$495.79 B-19.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$257.25 B-58.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$316.55 B-48.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$330.46 B-46.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$193.72 B-68.45%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$98.11 B-84.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$503.30 B-18.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$199.66 B-67.48%๐Ÿ‡ฌ๐Ÿ‡ง UK